nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP2E1—Fingolimod—multiple sclerosis	0.178	0.206	CbGbCtD
Chlorzoxazone—CYP2A6—Prednisolone—multiple sclerosis	0.111	0.129	CbGbCtD
Chlorzoxazone—CYP2D6—Fingolimod—multiple sclerosis	0.0848	0.0982	CbGbCtD
Chlorzoxazone—CYP2E1—Mitoxantrone—multiple sclerosis	0.0836	0.0969	CbGbCtD
Chlorzoxazone—CYP2A6—Dexamethasone—multiple sclerosis	0.0657	0.0761	CbGbCtD
Chlorzoxazone—CYP1A1—Dexamethasone—multiple sclerosis	0.0561	0.065	CbGbCtD
Chlorzoxazone—CYP3A4—Fingolimod—multiple sclerosis	0.0539	0.0625	CbGbCtD
Chlorzoxazone—CYP2E1—Dexamethasone—multiple sclerosis	0.0434	0.0502	CbGbCtD
Chlorzoxazone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0347	0.0403	CbGbCtD
Chlorzoxazone—CYP3A4—Triamcinolone—multiple sclerosis	0.0263	0.0305	CbGbCtD
Chlorzoxazone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0253	0.0294	CbGbCtD
Chlorzoxazone—CYP3A4—Betamethasone—multiple sclerosis	0.0226	0.0262	CbGbCtD
Chlorzoxazone—CYP3A4—Prednisolone—multiple sclerosis	0.0223	0.0258	CbGbCtD
Chlorzoxazone—CYP3A4—Prednisone—multiple sclerosis	0.021	0.0244	CbGbCtD
Chlorzoxazone—CYP2D6—Dexamethasone—multiple sclerosis	0.0207	0.0239	CbGbCtD
Chlorzoxazone—CYP3A4—Dexamethasone—multiple sclerosis	0.0131	0.0152	CbGbCtD
Chlorzoxazone—Urine color abnormal—Mitoxantrone—multiple sclerosis	0.0088	0.0819	CcSEcCtD
Chlorzoxazone—Chromaturia—Mitoxantrone—multiple sclerosis	0.00581	0.054	CcSEcCtD
Chlorzoxazone—Petechiae—Cladribine—multiple sclerosis	0.00383	0.0357	CcSEcCtD
Chlorzoxazone—Ecchymosis—Cladribine—multiple sclerosis	0.00285	0.0265	CcSEcCtD
Chlorzoxazone—Petechiae—Mitoxantrone—multiple sclerosis	0.00252	0.0234	CcSEcCtD
Chlorzoxazone—Petechiae—Prednisolone—multiple sclerosis	0.00207	0.0192	CcSEcCtD
Chlorzoxazone—Petechiae—Triamcinolone—multiple sclerosis	0.0019	0.0177	CcSEcCtD
Chlorzoxazone—Petechiae—Methylprednisolone—multiple sclerosis	0.0019	0.0176	CcSEcCtD
Chlorzoxazone—Ecchymosis—Mitoxantrone—multiple sclerosis	0.00187	0.0174	CcSEcCtD
Chlorzoxazone—Petechiae—Betamethasone—multiple sclerosis	0.00173	0.016	CcSEcCtD
Chlorzoxazone—Petechiae—Dexamethasone—multiple sclerosis	0.00173	0.016	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00171	0.0159	CcSEcCtD
Chlorzoxazone—KCNMA1—Potassium Channels—KCNA3—multiple sclerosis	0.00166	0.0564	CbGpPWpGaD
Chlorzoxazone—Ecchymosis—Prednisolone—multiple sclerosis	0.00154	0.0143	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Mitoxantrone—multiple sclerosis	0.00151	0.014	CcSEcCtD
Chlorzoxazone—Petechiae—Prednisone—multiple sclerosis	0.0015	0.014	CcSEcCtD
Chlorzoxazone—Ecchymosis—Triamcinolone—multiple sclerosis	0.00141	0.0132	CcSEcCtD
Chlorzoxazone—Ecchymosis—Methylprednisolone—multiple sclerosis	0.00141	0.0131	CcSEcCtD
Chlorzoxazone—Dizziness—Fingolimod—multiple sclerosis	0.00131	0.0122	CcSEcCtD
Chlorzoxazone—Ecchymosis—Dexamethasone—multiple sclerosis	0.00128	0.0119	CcSEcCtD
Chlorzoxazone—Ecchymosis—Betamethasone—multiple sclerosis	0.00128	0.0119	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Cladribine—multiple sclerosis	0.00128	0.0119	CcSEcCtD
Chlorzoxazone—Petechiae—Methotrexate—multiple sclerosis	0.00126	0.0117	CcSEcCtD
Chlorzoxazone—Malaise—Cladribine—multiple sclerosis	0.00124	0.0116	CcSEcCtD
Chlorzoxazone—Discomfort—Cladribine—multiple sclerosis	0.00116	0.0108	CcSEcCtD
Chlorzoxazone—Drowsiness—Mitoxantrone—multiple sclerosis	0.00116	0.0108	CcSEcCtD
Chlorzoxazone—Ecchymosis—Prednisone—multiple sclerosis	0.00112	0.0104	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Azathioprine—multiple sclerosis	0.00104	0.00968	CcSEcCtD
Chlorzoxazone—Malaise—Azathioprine—multiple sclerosis	0.00101	0.00941	CcSEcCtD
Chlorzoxazone—Somnolence—Cladribine—multiple sclerosis	0.001	0.00931	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000972	0.00904	CcSEcCtD
Chlorzoxazone—Discomfort—Azathioprine—multiple sclerosis	0.000943	0.00877	CcSEcCtD
Chlorzoxazone—Ecchymosis—Methotrexate—multiple sclerosis	0.000934	0.00869	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Cladribine—multiple sclerosis	0.000927	0.00863	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.000897	0.00835	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000841	0.00782	CcSEcCtD
Chlorzoxazone—Malaise—Mitoxantrone—multiple sclerosis	0.000817	0.0076	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00079	0.00735	CcSEcCtD
Chlorzoxazone—Discomfort—Mitoxantrone—multiple sclerosis	0.000762	0.00709	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Azathioprine—multiple sclerosis	0.000754	0.00701	CcSEcCtD
Chlorzoxazone—Dizziness—Cladribine—multiple sclerosis	0.000744	0.00692	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00074	0.00688	CcSEcCtD
Chlorzoxazone—KCNMA1—Neuronal System—KCNA3—multiple sclerosis	0.000726	0.0246	CbGpPWpGaD
Chlorzoxazone—Rash—Cladribine—multiple sclerosis	0.00071	0.0066	CcSEcCtD
Chlorzoxazone—Dermatitis—Cladribine—multiple sclerosis	0.000709	0.0066	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00069	0.00642	CcSEcCtD
Chlorzoxazone—Angioedema—Prednisolone—multiple sclerosis	0.00068	0.00632	CcSEcCtD
Chlorzoxazone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000672	0.0228	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000672	0.0228	CbGpPWpGaD
Chlorzoxazone—Malaise—Prednisolone—multiple sclerosis	0.000671	0.00624	CcSEcCtD
Chlorzoxazone—CYP2A6—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000661	0.0224	CbGpPWpGaD
Chlorzoxazone—Somnolence—Mitoxantrone—multiple sclerosis	0.000658	0.00612	CcSEcCtD
Chlorzoxazone—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000651	0.00606	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000635	0.0059	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000633	0.00589	CcSEcCtD
Chlorzoxazone—Discomfort—Prednisolone—multiple sclerosis	0.000626	0.00582	CcSEcCtD
Chlorzoxazone—Angioedema—Triamcinolone—multiple sclerosis	0.000625	0.00581	CcSEcCtD
Chlorzoxazone—Angioedema—Methylprednisolone—multiple sclerosis	0.000624	0.0058	CcSEcCtD
Chlorzoxazone—Malaise—Triamcinolone—multiple sclerosis	0.000617	0.00574	CcSEcCtD
Chlorzoxazone—Malaise—Methylprednisolone—multiple sclerosis	0.000615	0.00572	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00061	0.00567	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000607	0.00565	CcSEcCtD
Chlorzoxazone—Dizziness—Azathioprine—multiple sclerosis	0.000605	0.00563	CcSEcCtD
Chlorzoxazone—Drowsiness—Methotrexate—multiple sclerosis	0.000578	0.00538	CcSEcCtD
Chlorzoxazone—Rash—Azathioprine—multiple sclerosis	0.000577	0.00537	CcSEcCtD
Chlorzoxazone—Dermatitis—Azathioprine—multiple sclerosis	0.000576	0.00536	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000576	0.00536	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000576	0.00536	CcSEcCtD
Chlorzoxazone—Discomfort—Triamcinolone—multiple sclerosis	0.000575	0.00535	CcSEcCtD
Chlorzoxazone—Discomfort—Methylprednisolone—multiple sclerosis	0.000574	0.00534	CcSEcCtD
Chlorzoxazone—Angioedema—Dexamethasone—multiple sclerosis	0.000567	0.00527	CcSEcCtD
Chlorzoxazone—Angioedema—Betamethasone—multiple sclerosis	0.000567	0.00527	CcSEcCtD
Chlorzoxazone—Malaise—Betamethasone—multiple sclerosis	0.00056	0.00521	CcSEcCtD
Chlorzoxazone—Malaise—Dexamethasone—multiple sclerosis	0.00056	0.00521	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000558	0.00519	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000557	0.00518	CcSEcCtD
Chlorzoxazone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00054	0.0183	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00054	0.0183	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000533	0.0181	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000533	0.0181	CbGpPWpGaD
Chlorzoxazone—Discomfort—Dexamethasone—multiple sclerosis	0.000522	0.00486	CcSEcCtD
Chlorzoxazone—Discomfort—Betamethasone—multiple sclerosis	0.000522	0.00486	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000506	0.00471	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000506	0.00471	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000501	0.00466	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Prednisolone—multiple sclerosis	0.0005	0.00465	CcSEcCtD
Chlorzoxazone—Angioedema—Prednisone—multiple sclerosis	0.000494	0.00459	CcSEcCtD
Chlorzoxazone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000491	0.00457	CcSEcCtD
Chlorzoxazone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00049	0.00456	CcSEcCtD
Chlorzoxazone—Malaise—Prednisone—multiple sclerosis	0.000487	0.00453	CcSEcCtD
Chlorzoxazone—Rash—Mitoxantrone—multiple sclerosis	0.000466	0.00434	CcSEcCtD
Chlorzoxazone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000466	0.00433	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00046	0.00428	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000459	0.00427	CcSEcCtD
Chlorzoxazone—Discomfort—Prednisone—multiple sclerosis	0.000455	0.00423	CcSEcCtD
Chlorzoxazone—Dyspepsia—Betamethasone—multiple sclerosis	0.000446	0.00415	CcSEcCtD
Chlorzoxazone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000446	0.00415	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Prednisone—multiple sclerosis	0.000441	0.0041	CcSEcCtD
Chlorzoxazone—CYP2A6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000438	0.0149	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000438	0.0149	CbGpPWpGaD
Chlorzoxazone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000437	0.00407	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000437	0.00407	CcSEcCtD
Chlorzoxazone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000427	0.0145	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000427	0.0145	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000421	0.0143	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000421	0.0143	CbGpPWpGaD
Chlorzoxazone—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000419	0.0039	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000417	0.00388	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Betamethasone—multiple sclerosis	0.000417	0.00388	CcSEcCtD
Chlorzoxazone—Malaise—Methotrexate—multiple sclerosis	0.000407	0.00379	CcSEcCtD
Chlorzoxazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000404	0.0137	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000404	0.0137	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000403	0.0136	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000403	0.0136	CbGpPWpGaD
Chlorzoxazone—Dizziness—Prednisolone—multiple sclerosis	0.000401	0.00373	CcSEcCtD
Chlorzoxazone—CYP1A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000397	0.0135	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000397	0.0135	CbGpPWpGaD
Chlorzoxazone—Dyspepsia—Prednisone—multiple sclerosis	0.000388	0.00361	CcSEcCtD
Chlorzoxazone—KCNMA1—Hemostasis—CD58—multiple sclerosis	0.000383	0.013	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—MERTK—multiple sclerosis	0.000383	0.013	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—SELPLG—multiple sclerosis	0.000383	0.013	CbGpPWpGaD
Chlorzoxazone—Rash—Prednisolone—multiple sclerosis	0.000383	0.00356	CcSEcCtD
Chlorzoxazone—Dermatitis—Prednisolone—multiple sclerosis	0.000382	0.00356	CcSEcCtD
Chlorzoxazone—Discomfort—Methotrexate—multiple sclerosis	0.00038	0.00353	CcSEcCtD
Chlorzoxazone—Dizziness—Triamcinolone—multiple sclerosis	0.000369	0.00343	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000369	0.00343	CcSEcCtD
Chlorzoxazone—Dizziness—Methylprednisolone—multiple sclerosis	0.000368	0.00343	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Prednisone—multiple sclerosis	0.000363	0.00338	CcSEcCtD
Chlorzoxazone—Rash—Triamcinolone—multiple sclerosis	0.000352	0.00327	CcSEcCtD
Chlorzoxazone—Dermatitis—Triamcinolone—multiple sclerosis	0.000352	0.00327	CcSEcCtD
Chlorzoxazone—Rash—Methylprednisolone—multiple sclerosis	0.000351	0.00327	CcSEcCtD
Chlorzoxazone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000351	0.00326	CcSEcCtD
Chlorzoxazone—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000346	0.0117	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000346	0.0117	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000345	0.0117	CbGpPWpGaD
Chlorzoxazone—Dizziness—Betamethasone—multiple sclerosis	0.000335	0.00312	CcSEcCtD
Chlorzoxazone—Dizziness—Dexamethasone—multiple sclerosis	0.000335	0.00312	CcSEcCtD
Chlorzoxazone—Somnolence—Methotrexate—multiple sclerosis	0.000328	0.00305	CcSEcCtD
Chlorzoxazone—CYP1A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000326	0.0111	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000326	0.0111	CbGpPWpGaD
Chlorzoxazone—Dyspepsia—Methotrexate—multiple sclerosis	0.000324	0.00302	CcSEcCtD
Chlorzoxazone—Rash—Dexamethasone—multiple sclerosis	0.000319	0.00297	CcSEcCtD
Chlorzoxazone—Rash—Betamethasone—multiple sclerosis	0.000319	0.00297	CcSEcCtD
Chlorzoxazone—Dermatitis—Dexamethasone—multiple sclerosis	0.000319	0.00297	CcSEcCtD
Chlorzoxazone—Dermatitis—Betamethasone—multiple sclerosis	0.000319	0.00297	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000318	0.00296	CcSEcCtD
Chlorzoxazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000312	0.0106	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000312	0.0106	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Methotrexate—multiple sclerosis	0.000304	0.00283	CcSEcCtD
Chlorzoxazone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000303	0.0103	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000303	0.0103	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000299	0.0101	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000299	0.0101	CbGpPWpGaD
Chlorzoxazone—Dizziness—Prednisone—multiple sclerosis	0.000292	0.00271	CcSEcCtD
Chlorzoxazone—Rash—Prednisone—multiple sclerosis	0.000278	0.00259	CcSEcCtD
Chlorzoxazone—Dermatitis—Prednisone—multiple sclerosis	0.000278	0.00258	CcSEcCtD
Chlorzoxazone—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000276	0.00937	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000257	0.0087	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000257	0.0087	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000253	0.00859	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000253	0.00859	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000246	0.00833	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000246	0.00833	CbGpPWpGaD
Chlorzoxazone—Dizziness—Methotrexate—multiple sclerosis	0.000244	0.00227	CcSEcCtD
Chlorzoxazone—KCNMA1—Hemostasis—PLEK—multiple sclerosis	0.000237	0.00803	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—CYP27B1—multiple sclerosis	0.000233	0.00789	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—CYP24A1—multiple sclerosis	0.000233	0.00789	CbGpPWpGaD
Chlorzoxazone—Rash—Methotrexate—multiple sclerosis	0.000232	0.00216	CcSEcCtD
Chlorzoxazone—Dermatitis—Methotrexate—multiple sclerosis	0.000232	0.00216	CcSEcCtD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.00022	0.00746	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00022	0.00746	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000217	0.00735	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000208	0.00706	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000208	0.00706	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Neuronal System—BCHE—multiple sclerosis	0.000204	0.00691	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000198	0.00672	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000198	0.00672	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000195	0.00663	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000195	0.00663	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000191	0.00649	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000189	0.00639	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000184	0.00623	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000184	0.00623	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000181	0.00615	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000181	0.00615	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000178	0.00603	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—FAS—multiple sclerosis	0.000174	0.00588	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000173	0.00588	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000173	0.00588	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000171	0.0058	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000171	0.0058	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—SELE—multiple sclerosis	0.000167	0.00566	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000161	0.00544	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000161	0.00544	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000142	0.00481	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000138	0.00469	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000132	0.00449	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.00013	0.00442	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.00013	0.00442	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000129	0.00436	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000129	0.00436	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000122	0.00414	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000122	0.00412	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—ITGA4—multiple sclerosis	0.000121	0.00409	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.00012	0.00408	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—IFNB1—multiple sclerosis	0.00012	0.00406	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000111	0.00375	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000111	0.00375	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000109	0.0037	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000109	0.0037	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000102	0.00346	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.85e-05	0.00334	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.6e-05	0.00326	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	9.32e-05	0.00316	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.05e-05	0.00307	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	8.53e-05	0.00289	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	8.53e-05	0.00289	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.41e-05	0.00285	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.41e-05	0.00285	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	8.31e-05	0.00282	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	8.28e-05	0.00281	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—IL2RA—multiple sclerosis	8.24e-05	0.0028	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.79e-05	0.00264	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.34e-05	0.00249	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	7.09e-05	0.0024	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.81e-05	0.00231	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.66e-05	0.00226	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.66e-05	0.00226	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	6.47e-05	0.0022	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	6.46e-05	0.00219	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	6.33e-05	0.00215	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	6.03e-05	0.00204	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	6.03e-05	0.00204	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—ALB—multiple sclerosis	5.96e-05	0.00202	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Neuronal System—MAPK1—multiple sclerosis	5.95e-05	0.00202	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—IL6—multiple sclerosis	5.95e-05	0.00202	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	5.94e-05	0.00201	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.77e-05	0.00196	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—SRM—multiple sclerosis	5.65e-05	0.00191	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.52e-05	0.00187	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	5.3e-05	0.0018	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	5.28e-05	0.00179	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—POMC—multiple sclerosis	5.23e-05	0.00177	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—IL2—multiple sclerosis	4.83e-05	0.00164	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.68e-05	0.00159	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—SRM—multiple sclerosis	4.46e-05	0.00151	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.46e-05	0.00151	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.24e-05	0.00144	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.24e-05	0.00144	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—SRM—multiple sclerosis	4.21e-05	0.00143	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—POMC—multiple sclerosis	4.14e-05	0.0014	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.13e-05	0.0014	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.12e-05	0.0014	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.04e-05	0.00137	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	3.98e-05	0.00135	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	3.98e-05	0.00135	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—POMC—multiple sclerosis	3.9e-05	0.00132	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.84e-05	0.0013	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.84e-05	0.0013	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—TGFB1—multiple sclerosis	3.77e-05	0.00128	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—MAPK1—multiple sclerosis	3.7e-05	0.00125	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GPC5—multiple sclerosis	3.64e-05	0.00123	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.61e-05	0.00122	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	3.44e-05	0.00117	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SRM—multiple sclerosis	3.17e-05	0.00107	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	3.14e-05	0.00107	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	3.14e-05	0.00107	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—RRM1—multiple sclerosis	3.02e-05	0.00102	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	2.96e-05	0.00101	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	2.96e-05	0.00101	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.93e-05	0.000995	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.9e-05	0.000982	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.88e-05	0.000975	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GPC5—multiple sclerosis	2.71e-05	0.000919	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SRM—multiple sclerosis	2.68e-05	0.00091	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.49e-05	0.000843	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—RRM1—multiple sclerosis	2.38e-05	0.000808	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—RRM1—multiple sclerosis	2.25e-05	0.000762	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.23e-05	0.000757	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.23e-05	0.000757	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SRM—multiple sclerosis	2.07e-05	0.000702	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.04e-05	0.000692	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.92e-05	0.000651	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.89e-05	0.000641	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.89e-05	0.000641	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.85e-05	0.000626	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.74e-05	0.000591	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.73e-05	0.000587	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.73e-05	0.000586	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.69e-05	0.000573	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.5e-05	0.000508	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.46e-05	0.000495	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.46e-05	0.000495	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.43e-05	0.000486	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.37e-05	0.000464	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.37e-05	0.000463	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.33e-05	0.000452	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.29e-05	0.000438	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.11e-05	0.000377	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.11e-05	0.000375	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—APOE—multiple sclerosis	1.04e-05	0.000353	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—BCHE—multiple sclerosis	9.71e-06	0.000329	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.55e-06	0.000324	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—POMC—multiple sclerosis	8.95e-06	0.000303	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.7e-06	0.000295	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—APOE—multiple sclerosis	8.23e-06	0.000279	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—BCHE—multiple sclerosis	8.23e-06	0.000279	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ALB—multiple sclerosis	8.16e-06	0.000277	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—APOE—multiple sclerosis	7.76e-06	0.000263	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—POMC—multiple sclerosis	7.07e-06	0.00024	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—POMC—multiple sclerosis	6.67e-06	0.000226	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ALB—multiple sclerosis	6.45e-06	0.000219	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.35e-06	0.000215	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ALB—multiple sclerosis	6.08e-06	0.000206	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—APOE—multiple sclerosis	5.84e-06	0.000198	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—POMC—multiple sclerosis	5.02e-06	0.00017	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APOE—multiple sclerosis	4.95e-06	0.000168	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ALB—multiple sclerosis	4.58e-06	0.000155	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—POMC—multiple sclerosis	4.25e-06	0.000144	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ALB—multiple sclerosis	3.88e-06	0.000131	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOE—multiple sclerosis	3.82e-06	0.00013	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—POMC—multiple sclerosis	3.28e-06	0.000111	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ALB—multiple sclerosis	2.99e-06	0.000101	CbGpPWpGaD
